ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN SUPERCRITICAL CO2
ENANTIOMERIC RESOLUTION OF RACEMIC IBUPROFEN IN SUPERCRITICAL CO2
批准号:
2765207
负责人:
金额:
$0.08万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A common NSAID, ibuprofen, is marketed as a racemic mixture. It's
optically active isomer however, is more commercially valuable
particularly to the pharmaceutical industry. Within the past few
years investigators have been able to separate the enantiomers by
traditional crystallization techniques using L-lysine as a resolving
agent. This process, though successful, is time consuming because it
is dependent upon crystal formation. The use of supercritical fluids
affords a potential means to quick and inexpensive resolution. We
have developed a resolving agent suitable for a supercrititcal carbon
dioxide medium. Through preliminary molecular modeling studies using
a augmented form of Allinger's MM3 force field, this agent appears
sufficiently selective for the enantiomers of ibuprofen on a
theoretical basis. We have synthesized and characterized our
resolving agent, which is a fluorinated L-lysine derivative. Our
attempts and theoretical expectations of enantiomeri ibup rofen
separations in supercritical carbon dioxide will be related to the
effectiveness of chiral amino acid systems in non-traditional media.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金